Prime Medicine, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PRME Nasdaq 2836 primemedicine.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Prime Medicine, Inc.

We're Keeping An Eye On Prime Medicine's (NASDAQ:PRME) Cash Burn Rate - Jun 4th, 2026 6:29 am
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference - Jun 3rd, 2026 6:00 am
Prime Medicine to Present at Jefferies Global Healthcare Conference - May 28th, 2026 6:00 am
Prime Medicine (PRME) Reports Q1 EPS - May 13th, 2026 12:22 am
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 9:15 am
RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - May 7th, 2026 8:00 am
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates - May 7th, 2026 6:50 am
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates - May 7th, 2026 6:00 am
Prime Medicine (PRME) Appoints Svetlana Makhni as Chief Financial Officer - Apr 23rd, 2026 1:30 am
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer - Apr 16th, 2026 6:00 am
Prime Medicine (PRME) Focuses on Liver Franchise With $191.4M Cash Runway - Mar 8th, 2026 10:57 am
Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates - Mar 3rd, 2026 7:15 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates - Mar 3rd, 2026 6:00 am
Prime Medicine to Participate in Upcoming Investor Conferences - Feb 25th, 2026 6:00 am
Jacob Funds Bets on Prime Medicine (PRME), a Next-Generation Gene Therapy Company - Feb 18th, 2026 6:30 am
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates - Feb 11th, 2026 3:15 pm
Favourable Signals For Prime Medicine: Numerous Insiders Acquired Stock - Jan 27th, 2026 4:19 am
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - Jan 7th, 2026 6:00 am
LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases - Dec 31st, 2025 9:12 am
Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data - Dec 30th, 2025 9:45 pm